Suppression of Adipocyte Differentiation and Lipid Accumulation by Stearidonic Acid (SDA) in 3T3-L1 Cells
Overview
Endocrinology
Authors
Affiliations
Background: Increased consumption of omega-3 (ω-3) fatty acids found in cold-water fish and fish oil has been reported to protect against obesity. A potential mechanism may be through reduction in adipocyte differentiation. Stearidonic acid (SDA), a plant-based ω-3 fatty acid, has been targeted as a potential surrogate for fish-based fatty acids; however, its role in adipocyte differentiation is unknown. This study was designed to evaluate the effects of SDA on adipocyte differentiation in 3T3-L1 cells.
Methods: 3T3-L1 preadipocytes were differentiated in the presence of SDA or vehicle-control. Cell viability assay was conducted to determine potential toxicity of SDA. Lipid accumulation was measured by Oil Red O staining and triglyceride (TG) quantification in differentiated 3T3-L1 adipocytes. Adipocyte differentiation was evaluated by adipogenic transcription factors and lipid accumulation gene expression by quantitative real-time polymerase chain reaction (qRT-PCR). Fatty acid analysis was conducted by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS).
Results: 3T3-L1 cells treated with SDA were viable at concentrations used for all studies. SDA treatment reduced lipid accumulation in 3T3-L1 adipocytes. This anti-adipogenic effect by SDA was a result of down-regulation of mRNA levels of the adipogenic transcription factors CCAAT/enhancer-binding proteins alpha and beta (C/EBPα, C/EBPβ), peroxisome proliferator-activated receptor gamma (PPARγ), and sterol-regulatory element binding protein-1c (SREBP-1c). SDA treatment resulted in decreased expression of the lipid accumulation genes adipocyte fatty-acid binding protein (AP2), fatty acid synthase (FAS), stearoyl-CoA desaturase (SCD-1), lipoprotein lipase (LPL), glucose transporter 4 (GLUT4) and phosphoenolpyruvate carboxykinase (PEPCK). The transcriptional activity of PPARγ was found to be decreased with SDA treatment. SDA treatment led to significant EPA enrichment in 3T3-L1 adipocytes compared to vehicle-control.
Conclusion: These results demonstrated that SDA can suppress adipocyte differentiation and lipid accumulation in 3T3-L1 cells through down-regulation of adipogenic transcription factors and genes associated with lipid accumulation. This study suggests the use of SDA as a dietary treatment for obesity.
Fu M, Yoon K, Ha J, Kang I, Choe W Antioxidants (Basel). 2025; 14(2).
PMID: 40002389 PMC: 11852089. DOI: 10.3390/antiox14020203.
Bakondi E, Jung T, Marg S, Schnell V, Weber D, Schulz T Redox Rep. 2024; 29(1):2430882.
PMID: 39607809 PMC: 11610268. DOI: 10.1080/13510002.2024.2430882.
McTavish P, Mutch D Lipids Health Dis. 2024; 23(1):386.
PMID: 39567971 PMC: 11580630. DOI: 10.1186/s12944-024-02376-7.
Effect of Thai Herbal Remedy NL Inhibits Lipid Accumulation on 3T3-L1 Adipocyte Cells.
Warinhomhoun S, Viwatpinyo K, Nokkaew N, Limcharoen T, Ngamdokmai N Adv Pharmacol Pharm Sci. 2024; 2024:2350186.
PMID: 39564001 PMC: 11576086. DOI: 10.1155/2024/2350186.
lipopeptides inhibit lipase activity and promote 3T3-L1 preadipocyte differentiation.
Chen M, Chen D, Xiao R, Zheng X, Liu B, Wang J J Enzyme Inhib Med Chem. 2024; 39(1):2417915.
PMID: 39434248 PMC: 11497581. DOI: 10.1080/14756366.2024.2417915.